Loading
Latest filing published 29 Dec 2025 for Indaptus Therapeutics, Inc., €94k.
Not enough history yet: 1 closed purchase, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This profile gathers the share dealings of Walt Addison Linscott in Indaptus Therapeutics, Inc. Over a trading history stretching from 7 September 2022 to 22 December 2025, the count stands at 2 filings.
Purchases make up the whole of the open-market record (1 purchase, €393). Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 1 share grant.
Most recently, on 29 December 2025, the filings show a share grant worth €94k in Indaptus Therapeutics, Inc. The most recent open-market purchase was published on 9 September 2022, 1,506 days ago. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations